Find clinical trials for Acute Myeloid Leukemia (AML) in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Hanyang, Seoul, KOR:
to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...
Phase 1, Phase 2
Seoul, Seoul, South Korea and 33 other locations
Acute myeloid leukemia (AML) is an aggressive blood cancer, withwith few options for participants who relapse aft...
Phase 1
Seoul, Seoul Teugbyeolsi, South Korea and 6 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 3
Seoul, Seoul-T'Ukpyolshi, South Korea and 70 other locations
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain ...
Phase 3
Seoul, South Korea and 51 other locations
pharmacokinetics, pharmacodynamics and preliminary efficacy of ZE46-0134 in patients with FLT3 and spliceosome mutated Relapsed or Refractory Acute...
Phase 1
Seoul, South Korea and 22 other locations
inhibitor of MDM2 for the treatment of adults with FLT3 mutated Acute Myeloid Leukemia. Participants must be relapsed/refr...
Phase 1, Phase 2
Seoul, Korea, Republic of and 34 other locations
with azacitidine versus with azacitidine alone in participants with acute myeloid leukemia (AML) with the isocitr...
Phase 1, Phase 2
Seoul, South Korea and 48 other locations
This is an open-label, multi-center Phase 1 study of LY3410738, an oral, covalent isocitrate dehydrogenase (IDH) inhibitor, in patients with IDH1 and...
Phase 1
Seoul, Seoul-teukbyeolsi [Seoul], South Korea and 36 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Seoul, South Korea and 250 other locations
The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefi...
Phase 3
Seoul, Seoul Teugbyeolsi, South Korea and 55 other locations
Clinical trials
Research sites
Resources
Legal